• OPEN AN ACCOUNT
Indian Indices
Sensex
84,233.64 -40.28
( -0.05%)
Global Indices
Nasdaq
50,215.24 58.36
(0.12%)
Dow Jones
6,964.30 -21.52
(-0.31%)
Hang Seng
57,678.97 1,315.03
(2.33%)
Nikkei 225
10,354.92 -31.31
(-0.30%)
Forex
USD-INR
90.66 0.22
(0.24%)
EUR-INR
107.64 0.80
(0.75%)
GBP-INR
123.65 0.62
(0.51%)
JPY-INR
0.58 0.00
(0.85%)

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524742
INE475E01026
242.5445604
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CAPLIPOINT
36.35
13167.13
EPS(TTM)
Face Value()
Div & Yield %
47.66
2
0.35
 

As on: Feb 11, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,746.90 14.65 7922 36.35
Stock Price Details
Open Price() 1,733.10
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,755.00
Today's Low () 1,719.00
52-Week High () 2396.95
152-Week Low () 1551.05
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.35
Eps 47.66
Book Value 242.5445604
Market Cap (.Cr) 13,167.13
Face Value 2
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE475E01026


News
Caplin Point Laboratories consolidated net profit rises 17.93% in the December 2025 quarter
Caplin Point Laboratories to announce Quarterly Result
Volumes spurt at Honasa Consumer Ltd counter
Caplin Point Laboratories consolidated net profit rises 18.08% in the September 2025 quarter
Caplin Point Laboratories standalone net profit declines 2.98% in the September 2025 quarter
Caplin Point Laboratories to hold board meeting
Caplin Point gets USFDA approval for Nicardipine Hydrochloride injection
Caplin Point Laboratories Ltd - Caplin Point Laboratories Limited - Press Release
Caplin Point Laboratories Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Caplin Point Laboratories Ltd - Caplin Point Laboratories Limited - Trading Window
More
Corporate Details
Incoporation Year   : 1990
Chairman : C C Paarthipan
Bussiness Group : Indian Private
Registered Office
Caplin Point Laboratories Ltd
Ashvich Towers 3rd Floor,
No 3 Developed Plots Ind Estat,
Chennai,
Tamil Nadu-600096
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-44-24968000/71148000/28156653
Fax:91-44-28154952
Fax:91-22-66317458
E-Mail : investor@caplinpoint.net; info@caplinpoint.net
URL : http://www.caplinpoint.net


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE SmallCap
  • CNX 500
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi